Abstract: Data stored in relational databases can be retrieved using a relational database query language, while data stored in a multidimensional database is typically retrieved using a multidimensional database query language. However, most users do not have a functional working knowledge of multidimensional database query languages, which leaves large amounts of data inaccessible. Further, while some relational database query languages may be translated into a multidimensional database language, the information generated by such translations is often unusable, or returns large numbers of errors. In order to obtain effective translation of a relational database query language to a multidimensional database query language effective translation and filtering needs to occur. Using effective mapping and retrieval of database metadata along with effective, customizable business logic filtering of query components, more effective and reliable results may be achieved.

Abstract: Data stored in relational databases can be retrieved using a relational database query language, while data stored in a multidimensional database is typically retrieved using a multidimensional database query language. However, most users do not have a functional working knowledge of multidimensional database query languages, which leaves large amounts of data inaccessible. Further, while some relational database query languages may be translated into a multidimensional database language, the information generated by such translations is often unusable, or returns large numbers of errors. In order to obtain effective translation of a relational database query language to a multidimensional database query language effective translation and filtering needs to occur. Using effective mapping and retrieval of database metadata along with effective, customizable business logic filtering of query components, more effective and reliable results may be achieved.

Abstract: Methods are provided for screening for potential inhibitors of bacterial, or other microbial, global pathogenesis gene regulators and other gene regulators. Methods are also provided for treating microbial (e.g., bacterial) infections using such inhibitors. Also included are pharmaceutical compositions containing such inhibitors. The screening methods involve detecting whether the activity of a global pathogenesis gene regulator is altered in the presence of a test compound.